Bristol-Myers gets 'potentially revolutionary medicine' in MyoKardia deal, CEO says https://ift.tt/eA8V8J

"MyoKardia is an important company because they developed a really interesting approach to the treatment of cardiovascular disease," Bristol-Myers Squibb CEO Giovanni Caforio said.

from Business News https://ift.tt/3jFNraY

No comments:

Post a Comment